Tuberculosis of the spine in children - does drug resistance affect surgical outcomes?

Deepika Pinto1, Arjun Dhawale2, Ira Shah3

  • 1Department of Orthopaedics, Bai Jerbai Wadia Hospital for Children, Parel, Mumbai 400012, India.

Insights

Drug-resistant spinal tuberculosis (TB) in children is linked to worse surgical outcomes and higher complication rates. This study highlights the challenges in managing drug-resistant TB, emphasizing the need for careful surgical management in pediatric cases.

Area of Science:

  • Orthopedic Surgery
  • Pediatric Infectious Diseases
  • Spinal Tuberculosis Management

Background:

  • Drug resistance complicates spinal tuberculosis (TB) treatment.
  • Surgical outcomes for drug-resistant spinal TB in children are not well-studied.

Purpose of the Study:

  • To analyze surgical outcomes in children with spinal TB.
  • To determine if drug-resistant (DR) disease is associated with poorer surgical outcomes.

Main Methods:

  • Retrospective observational study of children treated for tuberculous spondylodiscitis.
  • Analysis of clinical and radiographic data, including neurological status, kyphosis angle, and complication rates.
  • Comparison of outcomes between drug-susceptible and drug-resistant TB cases.

Main Results:

  • Of 26 surgically treated children, 13 had drug-resistant TB requiring second-line anti-tuberculous therapy (ATT).
  • Neurological improvement occurred in most patients, but significant kyphosis worsening was noted.
  • A higher rate of major complications requiring revision surgery was observed in patients treated with second-line ATT.

Conclusions:

  • Drug-resistant spinal TB in children is associated with poorer surgical outcomes.
  • Higher complication rates are linked to drug-resistant spinal TB in pediatric patients.
Abstract

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
286
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
55
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
442
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
251
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
48